Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (8101)	11/23/2001 1:48:25 PM
From: tyc:>	Respond to of 14101

I do believe that the rules requiring disclosure of "material fact", explicitly exclude facts that are "conditional".

To: Joe Krupa who wrote (8101)	11/23/2001 1:49:26 PM
From: Cal Gary	Read Replies (3) \| Respond to of 14101

Hi Joe, If taken at another angle, bdalarge has a point. Let's assum RK has an approvable letter. With or without conditions. Material or not. It could be the first, second letter of many. Many other companies would NR this information and their stock price would go banannas!! RK should (read not forced) NR to support the ongoing financing. Aside: My lawyer would have written "RK shall NR to support the ongoing financing" <ggg> An NR about now would be more than reasonable. So "where's the beef?" that we can "eat it with a fork." Why doesn't RK let the world know there an approvable? Perhaps protocol. IMHO FDA: "great comfort and great confidence"